Stimpod NMS460’s revolutionary waveform generates electromagnetic effects, utilizing PRF which affects the cellular metabolic activity of a neuropathic nerve. The resulting cellular response changes the characteristics of the nerve, which in many cases causes the nerve to recover back to its normal function
Algiamed’s electromagnetic therapies are designed to restore the natural functionality of nerve cells using a non-invasive approach. The therapy is administered with a pen-like stimulation probe on the skin surface and elicits a light electrical sensation.
Our patented waveform delivers brief bursts of pulse stimulation triggering a long-lasting recovery through a metabolic biochemical cascade which targets the root cause of neurologically related diseases.
The induced electromagnetic field oscillates at frequencies in the range of the radio spectrum. It propagates as short bursts through the skin to the nerves and travels along the axons to the spinal dorsal horn, restoring the intra-neural communication pathways and the natural nerve functionality.
The short-burst electromagnetic stimulation in the radiofrequency range is what classifies Algiamed’s non-invasive electromagnetic therapies as PRF.
The STIMPOD NMS460 is cleared by the United States Food and Drug Administration and it complies with the essential requirements of the relevant European health, safety, and environmental protection legislation (CE certiﬁed).
"*" indicates required fields